Business / Finance

RSS

Eli and Edythe Broad Foundation gift $4 million to support UCLA research

Two new gifts from The Eli and Edythe Broad Foundation to UCLA totaling $4 million will fund research in stem cell science and digestive diseases and support the recruitment of key faculty at two renowned research centers.

9 May 2014

Smashburger partners with Udi's Gluten Free

Smashburger, the rapidly expanding better burger restaurant concept, today announced its new partnership with Udi's Gluten Free, rolling out a gluten-free bun offering at all U.S.

9 May 2014

Veracyte's revenue increases 71% to $7.5 million in Q1 2014

Veracyte, Inc. today reported financial results for the first quarter ended March 31, 2014, and provided an update on recent business progress. For the first quarter of 2014, revenue was $7.5 million, an increase of 71%, compared to $4.4 million for the first quarter of 2013.

9 May 2014

Clovis Oncology reports net loss of $30.7 million for first quarter 2014

Clovis Oncology, Inc. reported financial results for its first quarter ended March 31, 2014, and provided an update on the Company's clinical development programs for the rest of 2014.

9 May 2014

ApolloMed's revenues grow 35% to $10.5 million in fiscal 2014

Apollo Medical Holdings, Inc., an integrated, physician-centric healthcare delivery company, today announced financial results for the 12 months ended January 31, 2014.

9 May 2014

ImaginAb announces completion of $21M Series B financing

ImaginAb, Inc., a clinical stage biotechnology company that engineers antibodies into smaller protein formats optimized for in vivo molecular imaging, announced today the completion of a $21M Series B financing of the company, led by Mérieux Développement and syndicated with Novartis Venture Funds, Cycad Group and Nextech Invest.

9 May 2014

Dyadic International's total revenue for Q1 2014 up 20%

Dyadic International, Inc., a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and others proteins for the bioenergy, bio-based chemicals, biopharmaceutical and industrial enzyme industries, today announced financial results for the first quarter ended March 31, 2014.

8 May 2014

NxStage Medical reports revenue of $72.2 million for first quarter 2014

NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today reported record first quarter financial results that exceed the top end of its guidance range.

8 May 2014

IPM gains exclusive worldwide rights to promising HIV prevention medicine from Janssen R&D Ireland

The International Partnership for Microbicides announced today that it has received exclusive worldwide rights to a promising HIV prevention medicine called dapivirine from Janssen R&D Ireland, one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

8 May 2014

MAXIMUS revenue increases 35% to $439.0 million in second quarter fiscal 2014

MAXIMUS, a leading provider of government services worldwide, today reported financial results for the three and six months ended March 31, 2014.

8 May 2014

Kindred's consolidated revenues increase 2% to $1.30 billion in Q1 2014

Kindred Healthcare, Inc. today announced its operating results for the first quarter ended March 31, 2014.

7 May 2014

Ligand's total revenues increase 37% to $16.0 million in first quarter 2014

Ligand Pharmaceuticals Incorporated today reported financial results for the three months ended March 31, 2014, and provided an operating forecast and program updates.

7 May 2014

Rigel Pharmaceuticals reports net loss of $22.3 million for first quarter 2014

Rigel Pharmaceuticals, Inc. today reported financial results for the first quarter ended March 31, 2014.

7 May 2014

Streamline Health Solutions inks definitive agreement to acquire all assets of CentraMed

Streamline Health Solutions, Inc., a leading provider of transformational data-driven solutions to help healthcare providers reduce exposure to risk, enhance clinical, financial, and operational performance, and improve patient care, today announced that the Company has signed a definitive agreement to acquire substantially all of the assets of CentraMed, Inc.

7 May 2014